Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1988The Journal of AntibioticsOpen Access

Novel cholecystokinin antagonists from Aspergillus alliaceus. I. Fermentation, isolation, and biological properties.

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMichael GoetzUniversität UlmRMRichard L. MonaghanMerck & Co., Inc., Rahway, NJ, USA (United States)
Raymond S.L. Chang
Raymond S.L. ChangMerck & Co., Inc., Rahway, NJ, USA (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

GOETZ et al. (1988) studied this question.

synapsesocial.com/papers/6ab33ea8fc5692df778949e9https://doi.org/10.7164/antibiotics.41.875
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Structure elucidation.1985 · 69 citations
  2. 2A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus1985 · 320 citations
  3. 3Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.1985 · 95 citations